{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T04:19:06Z","timestamp":1727324346669},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,25]]},"DOI":"10.7759\/cureus.70174","type":"journal-article","created":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T15:07:40Z","timestamp":1727276860000},"source":"Crossref","is-referenced-by-count":0,"title":["Clogged Arteries, Safety Net Holes: Treating an Underinsured Patient for Homozygous Familial Hypercholesterolemia With Plasmapheresis"],"prefix":"10.7759","author":[{"given":"Parth","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iheoma","family":"Alinnor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Ann Kirkconnell","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lance T","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stacey","family":"Watkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.49121","article-title":"Familial hypercholesterolemia: a literature review of the pathophysiology and current and novel treatments","volume":"15","author":"Suryawanshi YN","year":"2023","unstructured":"Suryawanshi YN, Warbhe RA. Familial hypercholesterolemia: a literature review of the pathophysiology and current and novel treatments. Cureus. 2023, 15:e49121. 10.7759\/cureus.49121","journal-title":"Cureus"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2019.5173","article-title":"Reducing the clinical and public health burden of familial hypercholesterolemia: a global call to action","volume":"5","author":"Wilemon KA","year":"2020","unstructured":"Wilemon KA, Patel J, Aguilar-Salinas C, et al.. Reducing the clinical and public health burden of familial hypercholesterolemia: a global call to action. JAMA Cardiol. 2020, 5:217-29. 10.1001\/jamacardio.2019.5173","journal-title":"JAMA Cardiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-023-00892-0","article-title":"International Atherosclerosis Society guidance for implementing best practice in the care of familial hypercholesterolaemia","volume":"20","author":"Watts GF","year":"2023","unstructured":"Watts GF, Gidding SS, Hegele RA, et al.. International Atherosclerosis Society guidance for implementing best practice in the care of familial hypercholesterolaemia. Nat Rev Cardiol. 2023, 20:845-69. 10.1038\/s41569-023-00892-0","journal-title":"Nat Rev Cardiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.5551\/jat.RV17050","article-title":"Homozygous familial hypercholesterolemia","volume":"28","author":"Nohara A","year":"2021","unstructured":"Nohara A, Tada H, Ogura M, et al.. Homozygous familial hypercholesterolemia. J Atheroscler Thromb. 2021, 28:665-78. 10.5551\/jat.RV17050","journal-title":"J Atheroscler Thromb"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000297","article-title":"The agenda for familial hypercholesterolemia: a scientific statement from the American Heart Association","volume":"132","author":"Gidding SS","year":"2015","unstructured":"Gidding SS, Champagne MA, de Ferranti SD, et al.. The agenda for familial hypercholesterolemia: a scientific statement from the American Heart Association. Circulation. 2015, 132:2167-92. 10.1161\/CIR.0000000000000297","journal-title":"Circulation"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2012.02.019","article-title":"Homozygous familial hypercholesterolemia: current perspectives on diagnosis and treatment","volume":"223","author":"Raal FJ","year":"2012","unstructured":"Raal FJ, Santos RD. Homozygous familial hypercholesterolemia: current perspectives on diagnosis and treatment. Atherosclerosis. 2012, 223:262-8. 10.1016\/j.atherosclerosis.2012.02.019","journal-title":"Atherosclerosis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac339","article-title":"Aortic stenosis in homozygous familial hypercholesterolaemia: a paradigm shift over a century","volume":"43","author":"B\u00e9langer AM","year":"2022","unstructured":"B\u00e9langer AM, Akioyamen LE, Ruel I, Hales L, Genest J. Aortic stenosis in homozygous familial hypercholesterolaemia: a paradigm shift over a century. Eur Heart J. 2022, 43:3227-39. 10.1093\/eurheartj\/ehac339","journal-title":"Eur Heart J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccas.2019.07.023","article-title":"Novel presentation of homozygous familial hypercholesterolemia with homozygous variants in both LDLR and APOB genes","volume":"1","author":"Derenbecker R","year":"2019","unstructured":"Derenbecker R, Kapoor K, Brown E, et al.. Novel presentation of homozygous familial hypercholesterolemia with homozygous variants in both LDLR and APOB genes. JACC Case Rep. 2019, 1:346-9. 10.1016\/j.jaccas.2019.07.023","journal-title":"JACC Case Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccas.2022.08.017","article-title":"Evidence-based, mechanistic approach to the management of homozygous familial hypercholesterolemia","volume":"4","author":"Rosenson RS","year":"2022","unstructured":"Rosenson RS. Evidence-based, mechanistic approach to the management of homozygous familial hypercholesterolemia. JACC Case Rep. 2022, 4:1331-4. 10.1016\/j.jaccas.2022.08.017","journal-title":"JACC Case Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccas.2022.06.021","article-title":"Implementation of novel lipid therapies in a refractory heterozygous familial hypercholesterolemia patient with atherosclerotic disease","volume":"4","author":"Weintraub SF","year":"2022","unstructured":"Weintraub SF, Schillow JA, Azari BM, Hirsh BJ. Implementation of novel lipid therapies in a refractory heterozygous familial hypercholesterolemia patient with atherosclerotic disease. JACC Case Rep. 2022, 4:1327-30. 10.1016\/j.jaccas.2022.06.021","journal-title":"JACC Case Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/278794-clogged-arteries-safety-net-holes-treating-an-underinsured-patient-for-homozygous-familial-hypercholesterolemia-with-plasmapheresis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T15:07:42Z","timestamp":1727276862000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/278794-clogged-arteries-safety-net-holes-treating-an-underinsured-patient-for-homozygous-familial-hypercholesterolemia-with-plasmapheresis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,25]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.70174","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,25]]}}}